Lithuania vs Peru: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Lithuania
- Peru
How they compare
Peru currently reports 1,269 Cases against 21 Cases in Lithuania, a difference of 1,248 Cases.
That makes Peru's figure about 60.4 times Lithuania's.
Across all 20 years both countries report, Peru has been ahead every year.
Lithuania ranks 5th and Peru ranks 7th of 7 groups.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.2 Cases | 1,899 Cases | 1,868 Cases | Peru |
| 2010s | 36.8 Cases | 1,647 Cases | 1,610 Cases | Peru |
| 2020s | 28.8 Cases | 1,327 Cases | 1,298 Cases | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Lithuania or Peru?
- Peru, at 1,269 Cases against 21 Cases in Lithuania as of 2025.
- What is the difference in communicable diseases — communicable disease incidence between Lithuania and Peru?
- 1,248 Cases, with Peru ahead.
- How many years of comparable data are there for Lithuania and Peru?
- 20 years are reported by both, from 2005 to 2024.
- How do Lithuania and Peru rank globally for communicable diseases — communicable disease incidence?
- Lithuania ranks 5th and Peru ranks 7th of 7 groups.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.